FDA requests withdrawal of weight loss drug over cancer link
The FDA has issued a warning to anyone who takes the weight loss drug Belviq.
The FDA says Belviq has been linked to cancer, and it wants anyone taking the drug to stop.
The generic name for the drug is Lorcaserin. The FDA started investigating the drug last month.
Clinical trials showed people who take it could end up getting cancer.
The FDA asked the pharmaceutical company to take the drug off the market.
If you take Belviq, health officials say you probably don't need a special kind of cancer screening but you should talk to your doctor.